key: cord-0895500-zg627zwh authors: Iughetti, Lorenzo title: Pediatric inflammatory multisystem disease in children with COVID-19 - Reply date: 2021-05-12 journal: Acta Biomed DOI: 10.23750/abm.v92i2.10801 sha: e3dee0524b4b2c030d6e95cede366dfc0b97af04 doc_id: 895500 cord_uid: zg627zwh nan e L e t t e r : C o m m e n t s a n d R e s p o n s e s Dear colleagues, we thank you for sharing your ideas on our publication. This topic is as timely as ever, particularly due to new SARS-CoV-2 outbreak in European countries and persistent high number of contagions in the US. We cited the known possible association between coronaviruses and Kawasaki disease, as well as between many other viruses. What we wanted to underline is the epidemiological, clinical and laboratoristic difference between Kawasaki disease and this multinflammatory syndrome related to SARS-CoV-2. First of all, as we wrote, "the absence of reported cases of Kawasaki-like multisystem inflammatory syndrome associated with SARS-CoV-2 infection in Asia countries where the COVID-19 pandemic started, and where the incidence of KD is the highest, is noteworthy". As you say, it might be related to underlying genetic or immunological background (1) . Further studies should be conducted to analyze this point. About diagnosis, we know the possibility of false positive serology, and also false negative nasopharyngeal swabs (2) . It is interesting the observation that COVID 19 might co-exist with other infections, that might induce inflammatory multisystem manifestations. How-ever, no other infections where diagnosed in the cases descripted, both in Europe and US. Conflicts of interest: Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article. Multisystem inflammatory syndrome in children: Is there a linkage to Kawasaki disease? Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2